Inhibitors of bacterial growth
US10695322B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jan 26, 2017 |
| Grant date | Jun 30, 2020 |
| Priority date | — |
| Expiry date | Jan 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D499/897
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New antimicrobials targeting L,D-transpeptidases, non-classical cysteine peptidases, have been developed and their unique chemical structures identified. Carbapenems and penems of the present invention are unique among β-lactams as they acylate and inhibit L,D-transpeptidases, which likely results in their superior antimicrobial potency. These new antimicrobial agents can be used alone, or in combination with other classic antimicrobial agents that target D,D transpeptidases, when treating bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.